CLRO ClearOne beats Q2 earnings estimates despite continued losses yet shares slide 54 on outlook concerns DocuSign DOCU Stock Buyback Authorization Eye on Rally 20260427 ANTA Antalpha stock climbs 395 as strong 679 revenue growth overshadows EPS miss REPL Replimune Group rises nearly 8 percent after reporting narrower than expected Q1 2026 quarterly loss